...
机译:血红蛋白水平及其他因素对替莫唑胺术后放化疗联合序贯化疗对高级别胶质瘤患者的预后影响
Department of Radiation Oncology, “G. d’Annunzio” University of Chieti, SS. Annunziata Hospital, Chieti, Italy;
Department of Radiation Oncology, “G. d’Annunzio” University of Chieti, SS. Annunziata Hospital, Chieti, Italy;
Department of Radiation Oncology, “G. d’Annunzio” University of Chieti, SS. Annunziata Hospital, Chieti, Italy;
Department of Radiation Oncology, “G. d’Annunzio” University of Chieti, SS. Annunziata Hospital, Chieti, Italy;
Department of Radiation Oncology, “G. d’Annunzio” University of Chieti, SS. Annunziata Hospital, Chieti, Italy;
Department of Radiation Oncology, “G. d’Annunzio” University of Chieti, SS. Annunziata Hospital, Chieti, Italy;
Department of Neurosurgery, “G. d’Annunzio” University, Spirito Santo Hospital, Pescara, Italy;
Department of Operative Unit of Neurosurgery and Health Sciences, University of L’Aquila, San Salvatore Hospital, L’Aquila, Italy;
Labor;
Glioblastoma; Radiotherapy; Hemoglobin; Prognosis; Glioblastom; Radiotherapie; Hämoglobinspiegel; Prognose;
机译:血红蛋白水平和其他因素对根据替莫唑胺进行术后放化疗和序贯化疗的高级别神经胶质瘤患者的预后影响:在一家机构中拥有10年的经验。
机译:卡马汀薄饼或替莫唑胺治疗意向性治疗的高级神经胶质瘤患者的预后因素和生存
机译:使用卡莫司汀片或替莫唑胺治疗的高级脑胶质瘤患者的意向性治疗的预后因素和生存率
机译:ubumex结合AC-T顺序化疗对三重阴性乳腺癌患者血清T细胞亚群,OPN水平和生活质量的影响
机译:基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
机译:术后放化疗治疗重度脑胶质瘤患者认知障碍的危险因素
机译:全身免疫炎症指数,最低总淋巴细胞计数和血红蛋白水平是患者术后复发术后复兴治疗和化疗治疗食管癌的患者预后因素